{"version":"1.0","provider_name":"European Scientist","provider_url":"https:\/\/www.europeanscientist.com\/fr\/","author_name":"Gwladys Johnson","author_url":"https:\/\/www.europeanscientist.com\/fr\/author\/gwladys-johnson\/","title":"Covid-19\u00a0: bient\u00f4t un vaccin en vaporisateur nasal","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"pwlJseiMFm\"><a href=\"https:\/\/www.europeanscientist.com\/fr\/recherche\/covid-19-bientot-un-vaccin-en-vaporisateur-nasal\/\">Covid-19\u00a0: bient\u00f4t un vaccin en vaporisateur nasal<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.europeanscientist.com\/fr\/recherche\/covid-19-bientot-un-vaccin-en-vaporisateur-nasal\/embed\/#?secret=pwlJseiMFm\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Covid-19\u00a0: bient\u00f4t un vaccin en vaporisateur nasal\u00a0\u00bb &#8212; European Scientist\" data-secret=\"pwlJseiMFm\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.europeanscientist.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.europeanscientist.com\/wp-content\/uploads\/2022\/01\/collection-geec77b1c9_1920.jpg","thumbnail_width":1920,"thumbnail_height":1080,"description":"Le g\u00e9ant pharmaceutique Intravacc a annonc\u00e9 un partenariat avec le Dutch Leiden University Medical Center (LUMC) pour un vaccin anti-covid, administrable par pulv\u00e9risation nasale. D\u00e9nomm\u00e9 NANOVAC, le vaccin prot\u00e8ge directement les voies respiratoires sup\u00e9rieures, et neutralise le virus avant qu\u2019il n\u2019atteigne les poumons. La conception de ce type de vaccin le rend ainsi efficace contre [&hellip;]"}